Showing 231-240 of 1349 results for "".
Dermatology Practices Risk Losing Their APPs Without Improved Communications
https://practicaldermatology.com/topics/practice-management/dermatology-practices-risk-losing-their-apps-without-improved-communications/23282/There is plenty of uncertainty for most dermatology practices, but communicating with advanced staff about what is known can be important.AK Treatment Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-treatment-pearls/19731/Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-The Skin After Cancer
https://practicaldermatology.com/topics/general-topics/the-skin-after-cancer/20797/There are lots of questions, but still few answers. Here's what we know.What Do PAs Bring to the Table?
https://practicaldermatology.com/topics/practice-management/what-do-pas-bring-to-the-table/20342/Up to half of dermatologists in the US work with a PA or NP. Here's what to know about PAs and their role in practice.Is Your Dermatology Website Ready to Go Mobile?
https://practicaldermatology.com/topics/practice-management/go-mobile/18440/Know best practices for creating a mobile-friendly websites and preparing for Google's Mobile First index. Since 2015 mobile search has outpaced desktop search, and the gap is widening. Know what you need to succeed in this Ekwa.com Marketing Educational video.Rhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORChemoprevention Strategies for AK Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/chemoprevention-strategies-for-ak-patients/18822/Neal Bhatia, MD, Chief Medical Editor of Practical Dermatology®, provides strategies for treating actinic keratoses, as well as for prevention and management. He discusses the importance of sun protection and photodamage prevention, and says the key to treatment and maintenance is combination therapThe Resurgence of Ablative Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-resurgence-of-ablative-devices/18620/E. Victor Ross, MD, talks to host Joel L. Cohen, MD about the resurgence of traditional ablative devices. Dr. Ross says he never abandoned full-face CO2 resurfacing, but explains the key is to titrate the settings down—doing confluent 100 percent coverage but low-depth one pass on the forehead and cPruritus: A Marker For Cancer?
https://practicaldermatology.com/topics/practice-management/pruritus-a-marker-for-cancer/21181/Though the relationship is well known, new studies validate concerns regarding the link between pruritus and malignancy.